Literature DB >> 12707287

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

Richard J Johnson1, Duk-Hee Kang, Daniel Feig, Salah Kivlighn, John Kanellis, Susumu Watanabe, Katherine R Tuttle, Bernardo Rodriguez-Iturbe, Jaime Herrera-Acosta, Marilda Mazzali.   

Abstract

Hyperuricemia is associated with hypertension, vascular disease, renal disease, and cardiovascular events. In this report, we review the epidemiologic evidence and potential mechanisms for this association. We also summarize experimental studies that demonstrate that uric acid is not inert but may have both beneficial functions (acting as an antioxidant) as well as detrimental actions (to stimulate vascular smooth muscle cell proliferation and induce endothelial dysfunction). A recently developed experimental model of mild hyperuricemia also provides the first provocative evidence that uric acid may have a pathogenic role in the development of hypertension, vascular disease, and renal disease. Thus, it is time to reevaluate the role of uric acid as a risk factor for cardiovascular disease and hypertension and to design human studies to address this controversy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707287     DOI: 10.1161/01.HYP.0000069700.62727.C5

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  354 in total

1.  Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Authors:  Marian Goicoechea; Soledad García de Vinuesa; Ursula Verdalles; Caridad Ruiz-Caro; Jara Ampuero; Abraham Rincón; David Arroyo; José Luño
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Effects of SLC2A9 variants on uric acid levels in a Korean population.

Authors:  Jae Woong Sull; Eun Jung Park; Myoungsook Lee; Sun Ha Jee
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

3.  The kidney and hypertension.

Authors:  Katsumasa Kawahara; Kouju Kamata
Journal:  Clin Exp Nephrol       Date:  2012-02       Impact factor: 2.801

4.  Serum uric acid and cardiovascular disease.

Authors:  Adriana Iliesiu; Alexandru Campeanu; Dinu Dusceac
Journal:  Maedica (Buchar)       Date:  2010-07

5.  Uric acid: the past decade.

Authors:  Diana Rudan; Ozren Polasek; Ivana Kolcić; Igor Rudan
Journal:  Croat Med J       Date:  2010-02       Impact factor: 1.351

6.  Genome-wide scan identifies a quantitative trait locus at 4p15.3 for serum urate.

Authors:  Nik Cummings; Thomas D Dyer; Navaratnam Kotea; Sudhir Kowlessur; Pierrot Chitson; Paul Zimmet; John Blangero; Jeremy B M Jowett
Journal:  Eur J Hum Genet       Date:  2010-06-30       Impact factor: 4.246

Review 7.  Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?

Authors:  Mark S Segal; Elizabeth Gollub; Richard J Johnson
Journal:  Eur J Nutr       Date:  2007-09-01       Impact factor: 5.614

8.  Uric acid level and erectile dysfunction in patients with coronary artery disease.

Authors:  Yalcin Solak; Hakan Akilli; Mehmet Kayrak; Alpay Aribas; Abduzhappar Gaipov; Suleyman Turk; Santos E Perez-Pozo; Adrian Covic; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Sex Med       Date:  2013-09-25       Impact factor: 3.802

9.  Relationship between serum uric Acid and bone mineral density in the general population and in rats with experimental hyperuricemia.

Authors:  Dihua Zhang; I Alexandru Bobulescu; Naim M Maalouf; Beverley Adams-Huet; John Poindexter; Sun Park; Fuxin Wei; Christopher Chen; Orson W Moe; Khashayar Sakhaee
Journal:  J Bone Miner Res       Date:  2015-06       Impact factor: 6.741

Review 10.  Hyperuricemia and cardiovascular risk.

Authors:  Davide Grassi; Giovambattista Desideri; Anna Vittoria Di Giacomantonio; Paolo Di Giosia; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.